Chat with us

Ambrisentan (5mg) and Tadalafil (20mg) . (COMBO Of...

Ambrisentan (5mg) and Tadalafil (20mg). (COMBO Offer): Solution for Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension (PAH) is a rare and serious condition that can lead to debilitating symptoms, including shortness of breath, extreme fatigue, and chest pain. It affects the pulmonary arteries, which carry blood from the heart to the lungs, and causes them to constrict, raising blood pressure in the lungs and making it difficult for the heart to pump blood effectively. Managing PAH requires a multi-faceted approach, and one of the most promising therapies for this condition is the AMBRISTAR 5 + DURA 20 (COMBO offer), a combination therapy consisting of Ambrisentan (5mg) and Tadalafil (20mg). This combination not only targets the root causes of PAH but also offers a balanced solution to improve patient quality of life and manage the disease over the long term.

Understanding AMBRISTAR 5 + DURA 20:

AMBRISTAR 5 + DURA 20 is a fixed-dose combination medication designed specifically for the treatment of Pulmonary Arterial Hypertension (PAH), classified under WHO Group I. By combining Ambrisentan and Tadalafil, the therapy works on different mechanisms in the body that contribute to the increased pressure in the pulmonary arteries, making it a comprehensive treatment option for individuals living with PAH.

The Power of Ambrisentan (5mg):

Ambrisentan is an endothelin receptor antagonist (ERA) that targets endothelin-1, a powerful vasoconstrictor responsible for narrowing blood vessels. In the case of PAH, excessive endothelin-1 causes the pulmonary arteries to constrict, resulting in elevated pressure in the lungs. Ambrisentan works by selectively blocking the ETA and ETB receptors for endothelin-1, thereby reducing the vasoconstrictive effects and promoting vasodilation (relaxation of blood vessels).

By relaxing the pulmonary arteries, Ambrisentan helps reduce the strain on the heart, easing blood flow and lowering pulmonary arterial pressure. As a result, patients can experience reduced symptoms such as breathlessness, fatigue, and chest discomfort, leading to improved exercise capacity and a better quality of life.

The Role of Tadalafil (20mg):

Tadalafil, a well-known PDE-5 inhibitor, is widely used for its benefits in treating both erectile dysfunction and PAH. The drug works by inhibiting the phosphodiesterase type 5 (PDE-5) enzyme, which normally breaks down cyclic guanosine monophosphate (cGMP), a molecule that promotes smooth muscle relaxation in blood vessels. In patients with PAH, elevated PDE-5 activity reduces the levels of cGMP, preventing proper relaxation and dilation of the pulmonary arteries.

By blocking PDE-5, Tadalafil increases the levels of cGMP, leading to enhanced vasodilation in the pulmonary arteries. This helps to lower pulmonary artery pressure, improve blood flow to the lungs, and ultimately, ease the burden on the heart. Tadalafil also contributes to improving exercise capacity and reducing PAH-related symptoms.

The Synergy of AMBRISTAR 5 + DURA 20:

What makes AMBRISTAR 5 + DURA 20 a standout therapy is the synergistic action between Ambrisentan and Tadalafil. While Ambrisentan primarily works by blocking endothelin receptors and reducing vasoconstriction, Tadalafil works by increasing cGMP levels and further dilating the pulmonary arteries. This dual mechanism ensures that both the endothelial and smooth muscle components of the pulmonary arteries are addressed, leading to a more comprehensive approach to managing PAH.

In simple terms, AMBRISTAR 5 + DURA 20 provides a holistic solution for controlling pulmonary arterial pressure, improving blood flow, and reducing the symptoms of PAH. For patients, this means a greater improvement in quality of life, including increased ability to perform everyday tasks, better exercise tolerance, and a significant reduction in the feeling of breathlessness.

Key Benefits of AMBRISTAR 5 + DURA 20:

Improved Exercise Capacity: By lowering pulmonary arterial pressure and enhancing blood flow, AMBRISTAR 5 + DURA 20 helps increase exercise tolerance, enabling patients to perform daily activities with more ease.
Symptom Relief: The combination of Ambrisentan and Tadalafil effectively reduces the symptoms of PAH, such as shortness of breath, fatigue, and chest discomfort, leading to a more active and healthy lifestyle.
Dual Action: By combining two medications that target different pathways, AMBRISTAR 5 + DURA 20 offers a comprehensive and synergistic approach to managing PAH, improving the therapeutic outcome.
Prevention of Disease Progression: The combination helps slow the progression of PAH, potentially delaying the need for more invasive treatments such as surgery or lung transplantation.
Convenient Fixed-Dose Combination: The 5mg Ambrisentan + 20mg Tadalafil formulation makes it easier for patients to stick to their treatment regimen, improving adherence and ensuring consistent therapeutic benefits.

Usage and Dosage:

AMBRISTAR 5 + DURA 20 is taken once a day, as prescribed by your healthcare provider. It’s important to follow the prescribed dosage and consult your doctor before making any changes to your treatment. The tablet should be taken with or without food, and it is crucial to not exceed the recommended dosage.

Safety and Precautions:

While AMBRISTAR 5 + DURA 20 is generally well-tolerated, some patients may experience mild side effects, such as headaches, dizziness, nasal congestion, or flushing. Serious side effects are rare but can include liver problems, vision disturbances, or low blood pressure.

Patients with existing liver or kidney issues, or those taking medications for blood pressure or heart conditions, should consult their doctor before starting AMBRISTAR 5 + DURA 20.

Conclusion:

AMBRISTAR 5 + DURA 20 (COMBO offer) represents a breakthrough in the treatment of Pulmonary Arterial Hypertension. By combining the power of Ambrisentan (5mg) and Tadalafil (20mg), it offers a dual-action therapy that targets the root causes of PAH and provides relief from its debilitating symptoms.Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options. The company offers a wide range of healthcare products, catering to various medical needs, from rare disease treatments to essential healthcare products. Sterispharma\'s product range includes solutions for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. Medicines can be conveniently ordered via Our websites—Sterisonline, Sterisindia, and Sterispharma.